Short-term efficacy and toxicity of total neoadjuvant chemotherapy in patients with resectable gastric cancer

Short-term efficacy and toxicity of total neoadjuvant chemotherapy in patients with resectable gastric cancer

Background. Currently, perioperative chemotherapy is the standard treatment option for resectable gastric cancer (GC ) at stages higher than T1. Preoperative chemotherapy was shown do not adversely affect the course of the postoperative period in gastric cancer patients. However, approximately 60 %...

Full description

Bibliographic Details
Main Authors:	A. V. Avgustinovich, S. G. Afanasyev, A. Yu. Dobrodeev, M. Yu. Volkov, D. N. Kostromitsky, L. V. Spirina, O. V. Cheremisina
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2022-03-01
Series:	Сибирский онкологический журнал
Subjects:	резектабельный рак желудка комбинированное лечение тотальная неоадъювантная химиотерапия токсичность непосредственная эффективность
Online Access:	https://www.siboncoj.ru/jour/article/view/2023

Similar Items

ANALYSIS OF HEMATOLOGIC, HEPATIC AND PANCREATIC TOXICITY DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2018-07-01)

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER
by: E. M. Slonimskaya, et al.
Published: (2016-07-01)

ANALYSIS OF SAFETY OF NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER (RESULTS OF A MULTICENTER RANDOMIZED TRIAL)
by: V. Yu. Skoropad, et al.
Published: (2020-09-01)

CHEMOTHERAPY IN COMBINED MODALITY TREATMENT FOR LOCALLY ADVAMCED NON-SMALL CELL LUNG CANCER
by: Е. L. Yumov, et al.
Published: (2016-02-01)

EFFICACY OF COMBINED MODALITY TREATMENT INCLUDING NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH ESOPHAGEAL CANCER
by: Yu. V. Rudyk, et al.
Published: (2016-02-01)

Surgical management of cancer of the stomach and gastroesophageal junction after neoadjuvant therapy: the experience of the MRRC and literature review
by: V. Yu. Skoropad, et al.
Published: (2023-02-01)

Spleen-preserving D2 subtotal distal resection of the stomach and corpocaudal resection of the pancreas after neoadjuvant induction chemotherapy and chemoradiotherapy: case report and literature review
by: V. Yu. Skoropad, et al.
Published: (2022-11-01)

PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-07-01)

Short-term outcomes of neoadjuvant chemotherapy in colorectal cancer patients with isolated liver metastasis
by: A. Yu. Dobrodeev, et al.
Published: (2023-01-01)

ASSESSMENT OF HISTOPATHOLOGICAL RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN GASTRIC CANCER PATIENTS: A MULTI-CENTER RANDOMIZED STUDY
by: V. Yu. Skoropad, et al.
Published: (2020-10-01)

Short-term outcomes of preoperative chemotherapy in patients with upper ampullary rectal cancer
by: A. Yu. Dobrodeev, et al.
Published: (2022-01-01)

RISK OF DEVELOPING METACHRONIC CARCINOMAS IN GASTRIC CANCER PATIENTS TREATED WITH SURGERY ALONE AND IN COMBINATION WITH PREOPERATIVE AND INTRAOPERATIVE RADIATION THERAPY
by: G. O. Rukhadze, et al.
Published: (2016-02-01)

SURGICAL TREATMENT OF REGIONAL RECURRENCE FROM GASTRIC CANCER AFTER MULTIMODAL TREATMENT WITH NEOADJUVANT CHEMORADIOTHERAPY (A CASE REPORT)
by: V. Yu. Skoropad, et al.
Published: (2018-05-01)

MODERN METHODS OF TREATMENT OF PATIENTS WITH CANCER OF THE LARYNX AND HYPOPHARYNX
by: E. L. Choinzonov, et al.
Published: (2016-07-01)

PHASE 2 MULTICENTER RANDOMIZED CLINICAL TRIAL: NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2020-03-01)

PERSONALIZED APROACH TO POSTOPERATIVE CHEMOTHERAPY IN THE COMBINED MODALITY TREATMENT OF NON-SMALL CELL LUNG CANCER (CLINICAL CASE)
by: E. O. Rodionov, et al.
Published: (2016-07-01)

PLANNING PHASE 2 MULTICENTER RANDOMIZED TRIAL OF NEOADJUVANT CHEMO-RADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY AND ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED GASTRIC CANCER
by: V. Yu. Skoropad, et al.
Published: (2016-07-01)

Direct effectiveness of adding local hyperthermia to the scheme of neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: S. A. Ivanov, et al.
Published: (2020-09-01)

A CASE REPORT OF SUCCESSFUL TREATMENT OF STAGE IV ESOPHAGEAL CANCER
by: V. N. Khmelevskaya, et al.
Published: (2019-09-01)

mRNA expression of chemosensitivity genes as a predictor of response to neoadjuvant chemotherapy in non-small cell lung cancer
by: M. M. Tsyganov, et al.
Published: (2019-02-01)

A PARADIGM SHIFT IN THE TREATMENT OF PATIENTS WITH RESECTABLE PANCREATIC CANCER
by: E. Yu. Antonova, et al.
Published: (2020-07-01)

BRCA1 mRNA expression levels as an predictor of response to neoadjuvant chemotherapy in breast cancer
by: M. M. Tsyganov, et al.
Published: (2018-05-01)

MODERN ASPECTS OF TREATMENT OF ESOPHAGEAL CANCER
by: U. B. Urmonov, et al.
Published: (2019-09-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

A PERSONALIZED APPROACH TO ADJUVANT CHEMOTHERAPY FOR NON-SMALL CELL LUNG CANCER AFTER RADICAL SURGICAL TREATMENT BASED ON MOLECULAR MARKERS OF CHEMOSENSITIVITY
by: L. A. Efteev, et al.
Published: (2019-11-01)

HYPERTHERMIA IN TREATMENT OF NON-SMALL CELL LUNG CANCER
by: А. Yu. Dobrodeev, et al.
Published: (2016-02-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

COMPARATIVE ANALYSIS OF LONG-TERM RESULTS OF SURGICAL AND COMBINATION THERAPY FOR DIFFERENTIATED ADENOCARCINOMA AND UNDIFFERENTIATED GASTRIC CANCER
by: A. G. Davtyan, et al.
Published: (2016-02-01)

Clinical case of pathological complete response of gastric cancer after one cycle of neoadjuvant chemotherapy with fot regimen
by: V. Yu. Skoropad, et al.
Published: (2023-01-01)

POSSIBILITIES OF ORGAN-PRESERVING TREATMENT OF PATIENTS WITH MULTIPNEOADJUVANT COMBINATION CHEMOTHERAPY IN A PATIENT WITH CERVICAL CANCER IIIB STAGE WITH THE USE OF INTRA-ARTERIAL ADMINISTRATION OF PLATINUM DRUGS
by: A. G. Rerberg, et al.
Published: (2017-06-01)

Impact of adjuvant chemotherapy on relapse-free survival of patients with locally advanced cervical cancer
by: M. P. Smirnova, et al.
Published: (2022-01-01)

Impact of the histological regression grade of the primary tumor and regional lymph nodes after neoadjuvant chemoradiotherapy on survival of patients with gastric cancer: two case reports
by: V. Yu. Skoropad, et al.
Published: (2020-04-01)

RESULTS OF TREATMENT SICK OF THE STOMACH CANCER OF IV STAGE
by: Sh. Kh. Gantsev, et al.
Published: (2017-04-01)

MOTILITY-ASSOCIATED PROTEINS IN OVARIAN CANCER: RELATION WITH CLINICAL-MORPHOLOGICAL PARAMETERS AND NEOADJUVANT CHEMOTHERAPY RESPONSE
by: N. V. Yunusova, et al.
Published: (2016-02-01)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus’ko, et al.
Published: (2017-02-01)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)

CHEMOTHERAPY INFUSION INTO THE BRONCHIAL ARTERY IN THE COMBINED TREATMENT OF THE NON-SMAL CELL LUNG CANCER OF III STAGE
by: D. T. Arybzhanov, et al.
Published: (2017-01-01)

PATHOLOGICAL RESPONSE OF GASTRIC CANCER TO NEOADJUVANT PROLONGED CHEMORADIOTHERAPY FOLLOWED BY D2 GASTRECTOMY
by: Е. F. Lushnikov, et al.
Published: (2016-02-01)

RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS
by: Y. V. Kukharev, et al.
Published: (2016-02-01)